UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic

Transfusion (Philadelphia, Pa.), 2023-06, Vol.63 (6), p.1215-1223

2023

Volltextzugriff (PDF)

Optia® continuous mononuclear collection (CMNC) system is a safe and efficient system for hematopoietic progenitor cells‐apheresis (HPC‐a) collection and yields a lower product hematocrit (HCT%) than the COBE® spectra system: A retrospective study

Journal of clinical apheresis, 2018-08, Vol.33 (4), p.505-513

2018

Volltextzugriff (PDF)

A hands‐on resident umbilical cord blood educational curriculum compared to online education of post‐residency obstetricians: comparison of the volume of collected cord blood units

Transfusion (Philadelphia, Pa.), 2019-06, Vol.59 (6), p.2150-2154

2019

Volltextzugriff (PDF)

Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

British journal of haematology, 2008-12, Vol.143 (5), p.641-653

2008

Volltextzugriff (PDF)

M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion

Blood advances, 2018-04, Vol.2 (8), p.859-870

2018

Volltextzugriff (PDF)

Stem cell mobilization

Hematology, 2003, Vol.2003 (1), p.419-437

2003

Volltextzugriff (PDF)

Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients

Journal of immunotherapy (1997), 2015-01, Vol.38 (1), p.24-36

2015

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia: a cautionary tale

Transfusion (Philadelphia, Pa.), 2015-12, Vol.55 (12), p.2790-2790

2015

Volltextzugriff (PDF)

Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3

British journal of haematology, 2007-07, Vol.138 (2), p.176-185

2007

Volltextzugriff (PDF)

Validation of a formula for predicting daily CD34+ cell collection by leukapheresis

Cytotherapy (Oxford, England), 2012-04, Vol.14 (4), p.461-466

2012

Volltextzugriff (PDF)

Optimizing dendritic cell‐based immunotherapy in multiple myeloma: intranodal injections of idiotype‐pulsed CD40 ligand‐matured vaccines led to induction of type‐1 and cytotoxic T‐cell immune responses in patients

British journal of haematology, 2010-09, Vol.150 (5), p.554-564

2010

Volltextzugriff (PDF)

A comparison of washed and volume-reduced platelets with respect to platelet activation, aggregation, and plasma protein removal

Transfusion (Philadelphia, Pa.), 2011-05, Vol.51 (5), p.1030-1036

2011

Volltextzugriff (PDF)

Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A

Transfusion (Philadelphia, Pa.), 2003-01, Vol.43 (1), p.78-84

2003

Volltextzugriff (PDF)

DTPACE: An Effective, Novel Combination Chemotherapy With Thalidomide for Previously Treated Patients With Myeloma

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2732-2739

2003

Volltextzugriff (PDF)

Improved Outcome of Allogeneic Transplantation in High-Risk Multiple Myeloma Patients After Nonmyeloablative Conditioning

Journal of clinical oncology, 2002-03, Vol.20 (5), p.1295-1303

Badros, A.

2002

Volltextzugriff (PDF)

Mobilization of CD34+ cells in elderly patients (≥ 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen

British journal of haematology, 2003-02, Vol.120 (3), p.413-423

2003

Volltextzugriff (PDF)

Analysis of CD34+ cell collection using two mobilization regimens for newly diagnosed multiple myeloma patients reveals the separate impact of mobilization and collection variables

Journal of clinical apheresis, 2014-10, Vol.29 (5), p.251-255

2014

Volltextzugriff (PDF)

Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration

Cytotherapy (Oxford, England), 2010-10, Vol.12 (6), p.764-766

2010

Volltextzugriff (PDF)

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

Blood, 2001-05, Vol.97 (9), p.2574-2579

2001

Volltextzugriff (PDF)

Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy

Haematologica (Roma), 2008-11, Vol.93 (11), p.1739-1742

2008

Volltextzugriff (PDF)

Rituximab and intermediate‐purity plasma‐derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor

Journal of clinical apheresis, 2015-02, Vol.30 (1), p.50-54

2015

Volltextzugriff (PDF)

Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics

British journal of haematology, 2007-06, Vol.137 (6), p.530-536

2007

Volltextzugriff (PDF)

Complement Regulatory Genetic Mutations in the Setting of Autoimmune Thrombotic Thrombocytopenic Purpura: A Case Series

Mayo Clinic proceedings. Innovations, quality & outcomes, 2018-03, Vol.2 (1), p.69-73

2018

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Englisch
(127)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic

Optia® continuous mononuclear collection (CMNC) system is a safe and efficient system for hematopoietic progenitor cells‐apheresis (HPC‐a) collection and yields a lower product hematocrit (HCT%) than the COBE® spectra system: A retrospective study

A hands‐on resident umbilical cord blood educational curriculum compared to online education of post‐residency obstetricians: comparison of the volume of collected cord blood units

Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion

Stem cell mobilization

Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients

Heparin-induced thrombocytopenia: a cautionary tale

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3

Validation of a formula for predicting daily CD34+ cell collection by leukapheresis

Optimizing dendritic cell‐based immunotherapy in multiple myeloma: intranodal injections of idiotype‐pulsed CD40 ligand‐matured vaccines led to induction of type‐1 and cytotoxic T‐cell immune responses in patients

A comparison of washed and volume-reduced platelets with respect to platelet activation, aggregation, and plasma protein removal

Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A

DTPACE: An Effective, Novel Combination Chemotherapy With Thalidomide for Previously Treated Patients With Myeloma

Improved Outcome of Allogeneic Transplantation in High-Risk Multiple Myeloma Patients After Nonmyeloablative Conditioning

Mobilization of CD34+ cells in elderly patients (≥ 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen

Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3000 patients treated since 1989

Analysis of CD34+ cell collection using two mobilization regimens for newly diagnosed multiple myeloma patients reveals the separate impact of mobilization and collection variables

Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy

Rituximab and intermediate‐purity plasma‐derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor

Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics

Complement Regulatory Genetic Mutations in the Setting of Autoimmune Thrombotic Thrombocytopenic Purpura: A Case Series

Suchergebnisse filtern